The HIV-1 transgenic rat model of neuroHIV

Brain, Behavior, and Immunity
Michael VigoritoSulie L Chang

Abstract

Despite the ability of current combination anti-retroviral therapy (cART) to limit the progression of HIV-1 to AIDS, HIV-positive individuals continue to experience neuroHIV in the form of HIV-associated neurological disorders (HAND), which can range from subtle to substantial neurocognitive impairment. NeuroHIV may also influence substance use, abuse, and dependence in HIV-positive individuals. Because of the nature of the virus, variables such as mental health co-morbidities make it difficult to study the interaction between HIV and substance abuse in human populations. Several rodent models have been developed in an attempt to study the transmission and pathogenesis of the HIV-1 virus. The HIV-1 transgenic (HIV-1Tg) rat is a reliable model of neuroHIV because it mimics the condition of HIV-infected patients on cART. Research using this model supports the hypothesis that the presence of HIV-1 viral proteins in the central nervous system increases the sensitivity and susceptibility of HIV-positive individuals to substance abuse.

References

Nov 1, 1992·The International Journal of Neuroscience·B D Janković, J Radulović
Oct 1, 1991·Proceedings of the Society for Experimental Biology and Medicine·R R Gala
Oct 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·R A OlmstedP R Johnson
Jan 1, 1988·Neurology·L ResnickW W Tourtellotte
Mar 1, 1993·AIDS Research and Human Retroviruses·J B KoppP E Klotman
Jun 1, 1996·Brain Research. Cognitive Brain Research·H Hodges
Nov 26, 1996·Proceedings of the National Academy of Sciences of the United States of America·A Baddeley
Jan 1, 1996·Advances in Neuroimmunology·Y QiuJ Wang
May 1, 1997·Proceedings of the Society for Experimental Biology and Medicine·L Y Yu-Lee
Jul 23, 1998·Canadian Journal of Physiology and Pharmacology·A Herz
Jul 8, 1999·Proceedings of the National Academy of Sciences of the United States of America·M Kaul, S A Lipton
Nov 5, 1999·AIDS·C A WileyV Soontornniyomkij
Dec 14, 1999·The European Journal of Neuroscience·R D'hoogeP P De Deyn
Sep 23, 2000·Journal of Virology·C A PatelR J Pomerantz
Oct 7, 2000·Stroke; a Journal of Cerebral Circulation·N VilaA Chamorro
Nov 9, 2000·Lancet·A MocroftJ D Lundgren
Aug 2, 2001·Proceedings of the National Academy of Sciences of the United States of America·W ReidJ Bryant
Dec 12, 2001·Medical Hypotheses·M A AllerJ Arias
May 23, 2002·Recent Progress in Hormone Research·Li-Yuan Yu-Lee
Aug 2, 2002·Neuroreport·Marina R PicciottoBarbara J Caldarone
Oct 24, 2002·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Avi NathJadwiga T Turchan
Nov 19, 2002·Journal of Neurobiology·Marina R Picciotto, Michele Zoli
Mar 5, 2003·Trends in Immunology·Thomas J Rogers, Phillip K Peterson
May 20, 2003·Kidney International·Patricio E RayJoseph L Bryant
Jun 5, 2003·The American Journal of Psychiatry·Jaana SuvisaariJouko Lönnqvist
Jun 5, 2003·Nature Reviews. Neuroscience·Phuong B Tran, Richard J Miller
Nov 14, 2003·Schizophrenia Research·Sare J AkdagRobert W McCarley
Mar 17, 2004·Journal of Neuroimmunology·Frank M OcasioSulie L Chang
Mar 23, 2004·Virology·William ReidMarvin Reitz
Mar 27, 2004·Current HIV Research·Marc van Maanen, Richard E Sutton
Sep 9, 2004·Frontiers in Bioscience : a Journal and Virtual Library·Toru Hosoi, Yasuyuki Nomura
Dec 8, 2004·Critical Reviews in Neurobiology·Liana FattoreWalter Fratta
Feb 25, 2005·Proceedings of the National Academy of Sciences of the United States of America·Mary Jane PotashDavid J Volsky
May 12, 2005·Journal of Neuroimmunology·Ru ChenSulie L Chang
Sep 6, 2005·Pediatric Neurology·Andrew W ZimmermanMelvyn P Heyes
Nov 5, 2005·Neuroscience Letters·Británico González-LiraOscar Prospéro-García

❮ Previous
Next ❯

Citations

Mar 6, 2016·Journal of Neuroimmunology·William C ReidDima A Hammoud
Mar 12, 2016·Nature Reviews. Neurology·Deanna SaylorJustin C McArthur
Sep 18, 2015·Journal of Neuroinflammation·Dianne E LeeDima A Hammoud
May 6, 2016·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Zhongli YangSulie L Chang
Jun 7, 2016·Alcoholism, Clinical and Experimental Research·Xiangqian LiuSulie L Chang
Aug 18, 2016·The American Journal of Drug and Alcohol Abuse·Mollie A Monnig
Aug 20, 2016·Journal of Neurovirology·Kristen A McLaurinCharles F Mactutus
Oct 18, 2016·Frontiers in Immunology·Céline MarbanChristian Schwartz
Sep 7, 2016·Scientific Reports·Kristen A McLaurinCharles F Mactutus
May 20, 2018·Scientific Reports·Sarah J BertrandRosemarie M Booze
May 30, 2019·Alcoholism, Clinical and Experimental Research·Chi LiuXiao-Kang Li
Jan 11, 2018·Scientific Reports·Kristen A McLaurinCharles F Mactutus
Dec 21, 2017·Journal of Neurovirology·Jianlin HeSulie L Chang
Feb 27, 2017·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Guoku HuShilpa Buch
Nov 23, 2017·Frontiers in Behavioral Neuroscience·Kristen A McLaurinAmanda J Fairchild
Jun 23, 2018·Brain Structure & Function·Michael Ohene-NyakoT Celeste Napier
Feb 23, 2020·Journal of the Experimental Analysis of Behavior·Y Wendy HuynhJennifer E Murray
Mar 25, 2017·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Zhongli YangMing D Li
Sep 15, 2018·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Haijun HanMing D Li
Jan 3, 2018·PloS One·Amanda L PersonsT Celeste Napier
Jul 12, 2020·Fluids and Barriers of the CNS·Amila OmeragicReina Bendayan
Jan 4, 2017·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·Kristen A McLaurinCharles F Mactutus
Feb 1, 2020·Journal of Extracellular Vesicles·Raghubendra Singh DagurShilpa Buch
Apr 2, 2021·Neuroscience Letters·Susmita SilShilpa Buch
May 19, 2021·Journal of Neurovirology·Adam R DentonRosemarie M Booze
Aug 23, 2021·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Martina DonadoniIlker K Sariyer
Aug 3, 2021·The International Journal of Neuropsychopharmacology·Benjamin Z RobertsJared W Young

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Current Opinion in HIV and AIDS
Edwina J Wright
Journal of Acquired Immune Deficiency Syndromes : JAIDS
Desiree A ByrdCHARTER Group
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
François-Xavier LescureFrançoise Gray
Current Opinion in HIV and AIDS
Kelly A MeulendykeM Christine Zink
© 2022 Meta ULC. All rights reserved